T. Rowe Price Associates
KOD icon

T. Rowe Price Associates’s Kodiak Sciences KOD Stock Holding History

T. Rowe Price Associates’s Portfolio KOD Stock Details KOD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$127M Buy
3,248,611
+1,209,261
+59% +$47M 0.01% 633
2026
Q1 		$77.7M Buy
2,039,350
+869,171
+74% +$22.5M 0.01% 661
2025
Q4 		$32.7M Buy
1,170,179
+667,957
+133% +$13.7M ﹤0.01% 941
2025
Q3 		$8.22M Buy
502,222
+463,661
+1,202% +$4M ﹤0.01% 1276
2025
Q2 		$144K Buy
38,561
+2,790
+8% +$9.88K ﹤0.01% 2813
2025
Q1 		$101K Sell
35,771
-1,232,738
-97% -$6.7M ﹤0.01% 2821
2024
Q4 		$12.6M Buy
1,268,509
+1,257,063
+10,983% +$7.23M ﹤0.01% 1105
2024
Q3 		$30K Buy
+11,446
New +$30.4K ﹤0.01% 2971
2023
Q3 		– Sell
-494,463
Closed -$3.41M – 2901
2023
Q2 		$3.41M Buy
+494,463
New +$3.02M ﹤0.01% 1304
2023
Q1 		– Sell
-472,013
Closed -$3.38M – 2939
2022
Q4 		$3.38M Sell
472,013
-273,966
-37% -$1.97M ﹤0.01% 1271
2022
Q3 		$5.77M Buy
745,979
+89,561
+14% +$870K ﹤0.01% 1172
2022
Q2 		$5.01M Sell
656,418
-27,730
-4% -$195K ﹤0.01% 1422
2022
Q1 		$5.28M Sell
684,148
-7,432,314
-92% -$290M ﹤0.01% 1461
2021
Q4 		$688M Buy
8,116,462
+60,232
+0.7% +$6.13M 0.06% 291
2021
Q3 		$773M Buy
8,056,230
+643,080
+9% +$59.4M 0.07% 267
2021
Q2 		$689M Buy
7,413,150
+551,429
+8% +$52.9M 0.06% 289
2021
Q1 		$778M Buy
6,861,721
+685,510
+11% +$93.6M 0.08% 263
2020
Q4 		$907M Buy
6,176,211
+1,266,263
+26% +$141M 0.09% 230
2020
Q3 		$291M Buy
4,909,948
+66,321
+1% +$3.33M 0.03% 405
2020
Q2 		$262M Buy
4,843,627
+289,539
+6% +$16.3M 0.03% 416
2020
Q1 		$217M Buy
4,554,088
+477,861
+12% +$28.7M 0.03% 389
2019
Q4 		$293M Buy
4,076,227
+3,774,978
+1,253% +$137M 0.04% 402
2019
Q3 		$4.33M Buy
+301,249
New +$3.93M ﹤0.01% 1398

Other funds holding KOD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

T. Rowe Price Associates's KOD Position: Q2 2026 in Review

T. Rowe Price Associates increased its Kodiak Sciences (KOD) stake by 59% in Q2 2026, buying an estimated $47M and bringing the position to 3,248,611 shares worth $127M. The position accounts for 0.01% of the portfolio, ranked #633.

T. Rowe Price Associates first reported a position in KOD in Q3 2019 and has held it in 23 quarters since. The position peaked at $907M in Q4 2020. 200 funds tracked by Wall St. Rank hold KOD as of Q2 2026.

  • T. Rowe Price Associates held 3,248,611 shares of Kodiak Sciences worth $127M as of Q2 2026.
  • T. Rowe Price Associates bought 1,209,261 Kodiak Sciences shares in Q2 2026, an estimated $47M.
  • Kodiak Sciences made up 0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #633 holding.
  • T. Rowe Price Associates first reported a position in Kodiak Sciences in Q3 2019 and has held it in 23 quarters since.
  • T. Rowe Price Associates's Kodiak Sciences position peaked at $907M in Q4 2020.
  • 200 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.